A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus

NCT ID: NCT00212641

Last Updated: 2012-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

105 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this study are to characterize the pharmacodynamic profile, safety and tolerability of ONO-5129 in patients with Type 2 Diabetes mellitus

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ONO-5129

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Type 2 Diabetes Mellitus
2. FBG level \> 140 mg/dL and \< 270 mg/dL
3. Fasting TG level \< 500 mg/dL
4. BMI of 22 to 40 kg/m2, inclusive

Exclusion Criteria

1. Previous participation in an ONO-5129 protocol
2. Previous treatment with TZD agents or other current antidiabetics
3. History of myocardial infarction, coronary artery surgery, atrial/ventricular tachycardia, or atrial/ventricular fibrillation in the past six months
4. Presence of functional limitations due to cardiovascular disease in accordance with the New York Heart Association Classification System - Class III (moderate) or IV (severe)
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ono Pharma USA Inc

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joseph G Bisaha, Ph.D.

Role: STUDY_DIRECTOR

Ono Pharma USA Inc

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Apex Clinical Trials, Inc.

Birmingham, Alabama, United States

Site Status

Greystone Medical Research, LLC

Birmingham, Alabama, United States

Site Status

Med Search, LLC

Calera, Alabama, United States

Site Status

Medical Affiliated Research Center

Huntsville, Alabama, United States

Site Status

Clinic of Physicians and Surgeons

Mesa, Arizona, United States

Site Status

Horizon Clinical Research Associates

Mesa, Arizona, United States

Site Status

Cochise Clinical Research

Sierra Vista, Arizona, United States

Site Status

Sagebrush Medical Plaza, Department of Family Medicine

Bakersfield, California, United States

Site Status

Family Medical Center

Foothill Ranch, California, United States

Site Status

Prime-Care Clinical Research

Mission Viejo, California, United States

Site Status

Encompass Clinical Research

Spring Valley, California, United States

Site Status

Orange County Research Center

Tustin, California, United States

Site Status

Quality Care Medical Center

Vista, California, United States

Site Status

Arapahoe Internal Medicine

Littleton, Colorado, United States

Site Status

Institute Diabetes and Metabolic Disease

Newark, Delaware, United States

Site Status

Alliance Medical Reserach Group, Inc.

Clearwater, Florida, United States

Site Status

Personal Physician Care

Delray Beach, Florida, United States

Site Status

Century Clinical Research, Inc

Holly Hill, Florida, United States

Site Status

Innovative Research of West Florida

Largo, Florida, United States

Site Status

Cardiovascular Center of Sarasota

Sarasota, Florida, United States

Site Status

Executive Health and Research Associates, Inc.

Atlanta, Georgia, United States

Site Status

Capital City Family Medicine

Boise, Idaho, United States

Site Status

Orthopedic Health Care Clinic

Boise, Idaho, United States

Site Status

Sonora Clinical Research

Boise, Idaho, United States

Site Status

Cedar-Crosse Research Center

Chicago, Illinois, United States

Site Status

Chicago Research Center, Inc.

Chicago, Illinois, United States

Site Status

Heart of America Research

Shawnee, Kansas, United States

Site Status

Dolby Research, LLC

Baton Rouge, Louisiana, United States

Site Status

Acadia Clinical Research, LLC

Bangor, Maine, United States

Site Status

Franklin Square Hospital Center

Baltimore, Maryland, United States

Site Status

Centennial Medical Group

Elkridge, Maryland, United States

Site Status

Professional Clinical Reserach -Great Lakes Family Care

Cadillac, Michigan, United States

Site Status

Synergy Medical Education Alliance

Saginaw, Michigan, United States

Site Status

Medex Healthcare Research, Inc

St Louis, Missouri, United States

Site Status

Mercury Street Medical

Butte, Montana, United States

Site Status

Specialty Medical Center

Pahrump, Nevada, United States

Site Status

Bassett Healthcare

Cooperstown, New York, United States

Site Status

DiGiovanna Family Care Center

Great Neck, New York, United States

Site Status

United Physicians Group - Endocrine Division

Great Neck, New York, United States

Site Status

Winthrop University Hospital

Mineola, New York, United States

Site Status

New Horizons Clinical Research

Cincinnati, Ohio, United States

Site Status

Wells Institute for Health Awareness

Kettering, Ohio, United States

Site Status

Fallen Timbers Internal Medicine LLC

Maumee, Ohio, United States

Site Status

COR Clinical Reserch, LLC

Oklahoma City, Oklahoma, United States

Site Status

Cllinical Research Consultants

Medford, Oregon, United States

Site Status

Covance Clinical Research Unit, Inc

Portland, Oregon, United States

Site Status

Michael A. Azorr, M.D.

Portland, Oregon, United States

Site Status

Keystone Clinical Solutions

Altoona, Pennsylvania, United States

Site Status

Southeastern PA Medical Institute

Havertown, Pennsylvania, United States

Site Status

Greenand Seidner Family Practice

Lansdale, Pennsylvania, United States

Site Status

Thomas Jefferson University Div of Endocrinology

Philadelphia, Pennsylvania, United States

Site Status

Founders Medical Practice

Philadelphia, Pennsylvania, United States

Site Status

Research Endeavors

Pittsburgh, Pennsylvania, United States

Site Status

Hillcrest Clinical Research LLC

Simpsonville, South Carolina, United States

Site Status

Spartanburg Medical Research

Spartanburg, South Carolina, United States

Site Status

John Joseph, MD PA

Carrollton, Texas, United States

Site Status

Renaissance Clinical Research

Dallas, Texas, United States

Site Status

MCA Research

Houston, Texas, United States

Site Status

Southwest Houston Research, LTD

Houston, Texas, United States

Site Status

Professional for Clinical Research

Plano, Texas, United States

Site Status

Research Across America

Plano, Texas, United States

Site Status

Benjamin Garwood Research

San Antonio, Texas, United States

Site Status

WellMed at Northern Hills

San Antonio, Texas, United States

Site Status

Diabetes and Glandular Disease Research Associates

San Antonio, Texas, United States

Site Status

Diabetes and Glandular Disease - Westside office

San Antonio, Texas, United States

Site Status

Liberty Research Center

Tacoma, Washington, United States

Site Status

Hyperion Clinical Trials, Inc.

Charleston, West Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ONO-5129POU006

Identifier Type: -

Identifier Source: org_study_id